Vanessa Bolejack
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 20
- Cancer Treatment and Pharmacology 4
- Pancreatic and Hepatic Oncology Research 4
- Peptidase Inhibition and Analysis 4
-
- Sarcoma Diagnosis and Treatment 11
- Co-authors
- Bart Barlogie (11 shared papers)John Crowley (10 shared papers)Guido Tricot (7 shared papers)Maurizio Zangari (7 shared papers)Denise K. Reinke (10 shared papers)Mauricio Pineda‐Roman (6 shared papers)Frits van Rhee (6 shared papers)Klaus Hollmig (5 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Blood (5 papers)Cancer (3 papers)American Journal of Industrial Medicine (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Vanessa Bolejack
34 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 95
- Hematology 691
- Oncology 760
- Pulmonary and Respiratory Medicine 559
- Cancer Research 218
- Genetics 137
Countries citing papers authored by Vanessa Bolejack
This map shows the geographic impact of Vanessa Bolejack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Bolejack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Bolejack more than expected).
Fields of papers citing papers by Vanessa Bolejack
This network shows the impact of papers produced by Vanessa Bolejack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Bolejack. The network helps show where Vanessa Bolejack may publish in the future.
Co-authors
The 25 scholars most cited alongside Vanessa Bolejack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 245 | |
| 2 | 2019 | 174 | |
| 3 | 2010 | 149 | |
| 4 | 2014 | 148 | |
| 5 | 2007 | 126 | |
| 6 | 2010 | 114 | |
| 7 | 2016 | 95 | |
| 8 | 2019 | 82 | |
| 9 | 2006 | 61 | |
| 10 | 2014 | 56 | |
| 11 | 2003 | 55 | |
| 12 | 2014 | 47 | |
| 13 | 2006 | 45 | |
| 14 | 2005 | 41 | |
| 15 | 2017 | 31 | |
| 16 | 2022 | 30 | |
| 17 | 2017 | 29 | |
| 18 | 2007 | 23 | |
| 19 | 2018 | 23 | |
| 20 | 2016 | 18 |
About Vanessa Bolejack
Vanessa Bolejack is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Molecular Biology and Cancer Research, having authored 34 papers that have together received 1.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Sarcoma Diagnosis and Treatment (11 papers), Lymphoma Diagnosis and Treatment (5 papers), Protein Degradation and Inhibitors (4 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Hematology (691 citations), Oncology (760 citations), Pulmonary and Respiratory Medicine (559 citations), Cancer Research (218 citations) and Genetics (137 citations). Vanessa Bolejack has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Bart Barlogie, John Crowley, Guido Tricot, Maurizio Zangari, Denise K. Reinke, Mauricio Pineda‐Roman, Frits van Rhee, Klaus Hollmig, Kristen N. Ganjoo and Robert G. Maki. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer, American Journal of Industrial Medicine and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.